Notice of Meeting, 85550 [2024-24972]
Download as PDF
<![CDATA[
85550
Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Board
on Medical Rehabilitation Research.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/.
Name of Committee: National Advisory
Board on Medical Rehabilitation Research.
Date: December 2–3, 2024.
Time: December 02, 2024, 10:00 a.m. to
5:00 p.m.
Agenda: NICHD Director’s Report, NCMRR
Director’s report; NABMRR Liaison to NICHD
Advisory Council Report; Scientific Talk on
Collaboration; Report from the NIH Disability
Research Coordinating Committee; Scientific
Talk on Bilateral Task Training Post Stroke;
Updates on the NIH Research Plan on
Rehabilitation; Nominations for next Chair.
Address: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, 6710B Rockledge Drive,
Bethesda, MD 20817 (In Person and Virtual
Meeting).
Time: December 03, 2024, 10:00 a.m. to
2:00 p.m.
Agenda: Implementation of the NIH’s
Simplified Review Framework; Scientific
Talk on BCI; Election of Chair; Talk on
Community Engagement in Research;
Planning for next meeting in May 2025.
Address: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, 6710B Rockledge Drive,
Bethesda, MD 20817 (In Person and Virtual
Meeting).
Contact Person: Ralph M. Nitkin, Ph.D.,
Deputy Director, National Center for Medical
Rehabilitation, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6710B Rockledge
Drive, Room 2116, Bethesda, MD 20892–
7510, (301) 402–4206, nitkinr@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Persons listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
VerDate Sep<11>2014
19:13 Oct 25, 2024
Jkt 265001
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of an organization may
submit a letter of intent, a brief description
of the organization represented and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and
presentations may be limited to five minutes.
Both printed and electronic copies are
requested for the record. In addition, any
interested person may file written comments
with the committee by forwarding the
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/advisory/nabmrr,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 22, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–24982 Filed 10–25–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention’s
(CSAP) Drug Testing Advisory Board
(DTAB) will convene via web
conference on December 3, 2024, from
10 a.m. EST to 2:30 p.m. EST.
The board will meet in open session
December 3, 2024, from 10 a.m. EST to
2:30 p.m. EST to hear updates from the
Department of Transportation (DOT),
PO 00000
Frm 00063
Fmt 4703
Sfmt 9990
the Department of Defense (DoD) and
the Nuclear Regulatory Commission
(NRC), and updates from HHS on the
Federal Workplace Drug Testing
Program and Mandatory Guidelines.
Additionally, the board will hear
presentations regarding a collaboration
between the Department of Defense and
the Division of Workplace Programs as
well as data presented for consideration
regarding evaluation of the cutoff for an
invalid pH result in urine.
Data provided by HHS-certified
laboratories indicates that invalid urine
pH results cycle with the seasonal
temperature fluctuations. Data will be
presented to facilitate and inform
decisions regarding a possible
adjustment in the cutoff for urine pH to
reduce this cyclical effect while
continuing to identify potential
tampering of specimens.
Meeting registration information can
be completed at https://
snacregister.samhsa.gov/. Web
conference and call information will be
sent after completing registration.
Meeting information and a roster of
DTAB members may be obtained by
accessing the SAMHSA Advisory
Committees website, https://
www.samhsa.gov/about-us/advisorycouncils/meetings, or by contacting the
Designated Federal Officer, Lisa Davis.
Committee Name: Substance Abuse
and Mental Health Services
Administration, Center for Substance
Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: December 3, 2024,
from 10:00am EST to 2:30pm EST:
Open.
Place: Virtual.
To Submit Comments: Requests to
make public comment during the public
comment period of the December DTAB
meeting must be made in writing at least
7 days prior to the meeting to the
following email: DFWP@
samhsa.hhs.gov.
Contact: Lisa S. Davis, M.S, Social
Science Analyst, Center for Substance
Abuse Prevention, 5600 Fishers Lane,
Rockville, Maryland, 20857, Telephone:
(240) 276–1440, Email: Lisa.Davis@
samhsa.hhs.gov.
Anastasia Flanagan,
Public Health Advisor, Division of Workplace
Programs.
[FR Doc. 2024–24972 Filed 10–25–24; 8:45 am]
BILLING CODE 4162–20–P
E:\FR\FM\28OCN1.SGM
28OCN1
]]>Agencies
[Federal Register Volume 89, Number 208 (Monday, October 28, 2024)]
[Notices]
[Page 85550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24972]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory
Board (DTAB) will convene via web conference on December 3, 2024, from
10 a.m. EST to 2:30 p.m. EST.
The board will meet in open session December 3, 2024, from 10 a.m.
EST to 2:30 p.m. EST to hear updates from the Department of
Transportation (DOT), the Department of Defense (DoD) and the Nuclear
Regulatory Commission (NRC), and updates from HHS on the Federal
Workplace Drug Testing Program and Mandatory Guidelines. Additionally,
the board will hear presentations regarding a collaboration between the
Department of Defense and the Division of Workplace Programs as well as
data presented for consideration regarding evaluation of the cutoff for
an invalid pH result in urine.
Data provided by HHS-certified laboratories indicates that invalid
urine pH results cycle with the seasonal temperature fluctuations. Data
will be presented to facilitate and inform decisions regarding a
possible adjustment in the cutoff for urine pH to reduce this cyclical
effect while continuing to identify potential tampering of specimens.
Meeting registration information can be completed at https://snacregister.samhsa.gov/. Web conference and call information will be
sent after completing registration. Meeting information and a roster of
DTAB members may be obtained by accessing the SAMHSA Advisory
Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings, or by contacting the Designated Federal Officer, Lisa Davis.
Committee Name: Substance Abuse and Mental Health Services
Administration, Center for Substance Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: December 3, 2024, from 10:00am EST to 2:30pm EST:
Open.
Place: Virtual.
To Submit Comments: Requests to make public comment during the
public comment period of the December DTAB meeting must be made in
writing at least 7 days prior to the meeting to the following email:
[email protected].
Contact: Lisa S. Davis, M.S, Social Science Analyst, Center for
Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland,
20857, Telephone: (240) 276-1440, Email: [email protected].
Anastasia Flanagan,
Public Health Advisor, Division of Workplace Programs.
[FR Doc. 2024-24972 Filed 10-25-24; 8:45 am]
BILLING CODE 4162-20-P
